Area of research
Oncology · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Idiopathic pulmonary fibrosis, Pneumonia, Pulmonary fibrosis, and Pneumococcal pneumonia.
Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
Mortality and readmission in the year following hospitalization for pneumonia among US adults
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis
Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis
Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis
Rates of pneumonia among children and adults with chronic medical conditions in Germany
Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis